APA (7th ed.) Citation

Bray, M. L., Jahansouz, H., & Kaufman, M. J. (1999). Selection of Optimal Hydrate/Solvate Forms of a Fibrinogen Receptor Antagonist for Solid Dosage Development. Pharmaceutical development and technology, 4(1), 81-87. https://doi.org/10.1080/10837459908984227

Chicago Style (17th ed.) Citation

Bray, Michelle L., Hossain Jahansouz, and Michael J. Kaufman. "Selection of Optimal Hydrate/Solvate Forms of a Fibrinogen Receptor Antagonist for Solid Dosage Development." Pharmaceutical Development and Technology 4, no. 1 (1999): 81-87. https://doi.org/10.1080/10837459908984227.

MLA (9th ed.) Citation

Bray, Michelle L., et al. "Selection of Optimal Hydrate/Solvate Forms of a Fibrinogen Receptor Antagonist for Solid Dosage Development." Pharmaceutical Development and Technology, vol. 4, no. 1, 1999, pp. 81-87, https://doi.org/10.1080/10837459908984227.